BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 86158)

  • 1. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoresis of vidarabine monophosphate for herpes orolabialis.
    Gangarosa LP; Hill JM; Thompson BL; Leggett C; Rissing JP
    J Infect Dis; 1986 Dec; 154(6):930-4. PubMed ID: 2431074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.
    Milman N; Scheibel J; Jessen O
    Acta Derm Venereol; 1980; 60(1):85-7. PubMed ID: 6153847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparison of two topical antiviral ointments in herpes].
    Makleit L; Nagy M
    Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ether and herpes simplex labialis.
    Guinan ME; MacCalman J; Kern ER; Overall JC; Spruance SL
    JAMA; 1980 Mar; 243(10):1059-61. PubMed ID: 6243714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.
    Whitley RJ; Soong SJ; Dolin R; Galasso GJ; Ch'ien LT; Alford CA
    N Engl J Med; 1977 Aug; 297(6):289-94. PubMed ID: 195208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes labialis treatment with acyclovir 5 per cent ointment.
    Raborn GW; McGaw WT; Grace M; Houle L
    J Can Dent Assoc; 1989 Feb; 55(2):135-7. PubMed ID: 2645030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis.
    DiGiovanna JJ; Blank H
    Arch Dermatol; 1984 Jan; 120(1):48-51. PubMed ID: 6419679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of herpes simplex virus encephalitis in mice by direct intracerebral injection.
    Cameron KR; Adams DH
    J Infect Dis; 1979 Dec; 140(6):921-6. PubMed ID: 94338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections.
    Myers MG; Oxman MN; Clark JE; Arndt KA
    N Engl J Med; 1975 Nov; 293(19):945-9. PubMed ID: 170521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient hosts.
    Aiuti F; Sirianni MC; Paganelli R; Stella A; Turbessi G; Fiorilli M
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):81-6. PubMed ID: 6341261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of herpes labialis with chloroform.
    Taylor CA; Hendley JO; Greer KE; Gwaltney JM
    Arch Dermatol; 1977 Nov; 113(11):1550-2. PubMed ID: 931393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of herpes simplex labialis.
    Spruance SL; Kriesel JD
    Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.